A prospective, multi-centre study (B-Sure) to evaluate long-term durability of treatment response in chronic hepatitis B participants with and without nucleos(t)ide therapy who have participated in a previous bepirovirsen treatment study.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
SYNEOS HEALTH UK LIMITED
Cita
A prospective, multi-centre study (B-Sure) to evaluate long-term durability of treatment response in chronic hepatitis B participants with and without nucleos(t)ide therapy who have participated in a previous bepirovirsen treatment study. (206882). SYNEOS HEALTH UK LIMITED. 2025IP:MARÍA GARCÍA ELIZ.
Portal de investigación